NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $69.93
  • Forecasted Upside: 6.19 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
▲ +2.88 (4.57%)

This chart shows the closing price for THC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

Analyst Price Target is $69.93
▲ +6.19% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $69.93, with a high forecast of $88.00 and a low forecast of $36.00. The average price target represents a 6.19% upside from the last price of $65.85.

This chart shows the closing price for THC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 17 polled investment analysts is to buy stock in Tenet Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2021Truist SecuritiesLower Price TargetHold$78.00 ➝ $72.00Medium
10/13/2021TruistLower Price TargetHold$78.00 ➝ $72.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$80.00High
9/23/2021UBS GroupInitiated CoverageNeutral$83.00Medium
9/8/2021BarclaysBoost Price TargetOverweight$78.00 ➝ $79.00Low
8/12/2021BarclaysUpgradeEqual Weight ➝ Overweight$62.00 ➝ $77.00Medium
8/9/2021MizuhoBoost Price TargetBuy$70.00 ➝ $75.00Low
7/23/2021Credit Suisse GroupBoost Price TargetOutperform$71.00 ➝ $88.00Medium
7/23/2021CitigroupInitiated CoverageBuy$70.84Medium
7/23/2021Royal Bank of CanadaBoost Price TargetOutperform$78.00 ➝ $83.00Medium
7/23/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$69.00 ➝ $80.00Medium
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
7/9/2021Seaport Global SecuritiesInitiated CoverageBuy$80.00High
6/18/2021Jefferies Financial GroupReiterated RatingBuyHigh
5/5/2021MizuhoBoost Price TargetBuy$55.00 ➝ $70.00Low
5/3/2021The Goldman Sachs GroupInitiated CoverageBuyHigh
4/23/2021BarclaysBoost Price Target$55.00 ➝ $62.00High
4/22/2021Truist SecuritiesBoost Price Target$56.00 ➝ $60.00Medium
4/22/2021TruistBoost Price Target$56.00 ➝ $60.00High
4/22/2021CitigroupBoost Price Target$58.00 ➝ $65.00High
4/22/2021Credit Suisse GroupBoost Price TargetOutperform$58.00 ➝ $71.00High
4/22/2021Royal Bank of CanadaBoost Price TargetOutperform$57.00 ➝ $66.00High
4/9/2021MizuhoBoost Price TargetBuy$48.00 ➝ $55.00Medium
2/11/2021CitigroupBoost Price Target$50.00 ➝ $58.00Low
2/11/2021Credit Suisse GroupBoost Price TargetOutperform$52.00 ➝ $58.00Low
1/21/2021UBS GroupBoost Price TargetPositive ➝ Buy$37.00 ➝ $60.00High
1/14/2021Raymond JamesBoost Price TargetOutperform$55.00 ➝ $60.00High
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$27.00 ➝ $60.00Low
1/5/2021Bank of AmericaUpgradeNeutral ➝ Buy$45.00 ➝ $50.00N/A
12/18/2020MizuhoBoost Price TargetBuy$32.00 ➝ $48.00Medium
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyMedium
12/11/2020Smith Barney CitigroupBoost Price Target$33.00 ➝ $50.00High
12/11/2020Credit Suisse GroupBoost Price TargetOutperform$39.00 ➝ $48.00Medium
12/11/2020BarclaysBoost Price TargetEqual Weight$28.00 ➝ $46.00High
11/11/2020Piper SandlerBoost Price TargetNeutral$31.00 ➝ $36.00High
11/9/2020MizuhoBoost Price TargetBuy$30.00 ➝ $32.00High
10/22/2020Raymond JamesBoost Price TargetOutperform$40.00 ➝ $43.00High
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$28.00 ➝ $20.00High
9/4/2020Royal Bank of CanadaBoost Price Target$30.00 ➝ $35.00Low
8/14/2020TruistBoost Price Target$21.00 ➝ $30.00Medium
8/10/2020UBS GroupBoost Price TargetBuy$30.00 ➝ $35.00Low
8/5/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$25.00 ➝ $28.00High
8/4/2020Credit Suisse GroupReiterated RatingBuyHigh
6/11/2020UBS GroupLower Price TargetBuy$32.00 ➝ $30.00High
5/29/2020MizuhoLower Price TargetBuy$32.00 ➝ $30.00High
5/21/2020SunTrust BanksBoost Price TargetHold$22.00 ➝ $25.00Medium
5/20/2020CitigroupLower Price TargetBuy$35.00 ➝ $27.00High
5/14/2020UBS GroupLower Price TargetBuy$49.00 ➝ $32.00High
5/11/2020BarclaysBoost Price TargetEqual Weight$19.00 ➝ $22.00Low
5/6/2020Credit Suisse GroupReiterated RatingBuy$33.00Low
5/6/2020Wells Fargo & CompanyLower Price TargetEqual Weight$40.00 ➝ $32.00Low
5/6/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$31.00 ➝ $25.00High
4/13/2020SunTrust BanksBoost Price TargetHold$18.00 ➝ $22.00Low
4/13/2020Royal Bank of CanadaReiterated RatingBuy$26.00Medium
4/3/2020SunTrust BanksLower Price TargetHold$42.00 ➝ $18.00High
3/25/2020BarclaysReiterated RatingHold$19.00High
3/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$32.00 ➝ $39.00High
2/26/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$31.00 ➝ $32.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$20.00Low
12/20/2019JPMorgan Chase & Co.Boost Price TargetUnderweight$23.00 ➝ $31.00Medium
12/18/2019SunTrust BanksBoost Price TargetHold$31.00 ➝ $42.00Medium
12/9/2019UBS GroupUpgradeNeutral ➝ Buy$24.00 ➝ $53.00High
11/7/2019MizuhoReiterated RatingBuyLow
11/6/2019MizuhoBoost Price Target$30.00 ➝ $33.00Low
11/6/2019SunTrust BanksBoost Price TargetHold$24.00 ➝ $31.00High
11/6/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$25.00 ➝ $36.00High
8/14/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$28.00 ➝ $28.00High
8/11/2019Royal Bank of CanadaReiterated RatingHold$26.00Medium
8/7/2019SunTrust BanksSet Price TargetHold$24.00Low
5/1/2019SunTrust BanksLower Price TargetHold$27.00High
4/17/2019BarclaysSet Price TargetHold$24.00Medium
2/27/2019Raymond JamesBoost Price Target$37.00 ➝ $47.00Medium
2/27/2019CitigroupBoost Price TargetBuy ➝ Buy$35.00 ➝ $37.00High
2/26/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$21.00 ➝ $30.00High
1/28/2019MizuhoReiterated RatingBuy$28.00Low
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$23.00Medium
1/6/2019BarclaysReiterated RatingHold$20.00High
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$20.00Low
12/17/2018Robert W. BairdDowngradeOutperform ➝ NeutralHigh
12/3/2018Raymond JamesReiterated RatingBuy$37.00High
11/15/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$26.00Low
11/7/2018Robert W. BairdReiterated RatingBuy$35.00High
11/7/2018BarclaysReiterated RatingHold$27.00High
8/14/2018BarclaysInitiated CoverageEqual Weight$35.00Low
8/10/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$22.00 ➝ $28.00Low
8/8/2018Piper Jaffray CompaniesReiterated RatingHold$34.00Medium
8/8/2018SunTrust BanksReiterated RatingHold$35.00Medium
8/7/2018MizuhoSet Price TargetBuy$36.00Medium
7/23/2018CitigroupBoost Price TargetBuy ➝ Buy$37.00 ➝ $44.00High
6/29/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$28.00 ➝ $38.00Medium
5/9/2018MizuhoReiterated RatingBuy$35.00Medium
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$27.00 ➝ $37.00Low
5/4/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$27.00 ➝ $33.00Low
5/2/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$16.00 ➝ $24.00High
5/2/2018SVB LeerinkBoost Price TargetOutperform$30.00 ➝ $40.00High
4/17/2018SunTrust BanksReiterated RatingHold$27.00Low
3/22/2018MizuhoReiterated RatingBuy$29.00High
3/5/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$15.00 ➝ $18.00Low
3/1/2018Piper Jaffray CompaniesReiterated RatingHold$21.00High
3/1/2018SunTrust BanksReiterated RatingHoldHigh
3/1/2018CitigroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $27.00Low
2/28/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$15.00 ➝ $16.00Medium
2/28/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $22.00High
2/28/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$30.00High
2/27/2018Jefferies Financial GroupSet Price TargetBuy$23.00Low
1/30/2018Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$20.00High
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$15.00High
12/20/2017SVB LeerinkReiterated RatingBuy$27.00Low
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$14.00Medium
12/19/2017MizuhoBoost Price TargetNeutral$13.00 ➝ $15.00High
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$15.00Medium
12/12/2017CitigroupUpgradeNeutral ➝ BuyHigh
11/21/2017William BlairReiterated RatingMarket PerformN/A
11/13/2017Royal Bank of CanadaLower Price TargetSector Perform$19.00 ➝ $17.00N/A
11/10/2017MizuhoReiterated RatingNeutral ➝ HoldN/A
11/9/2017Morgan StanleyLower Price TargetEqual Weight$15.00 ➝ $14.00N/A
11/8/2017SVB LeerinkReiterated RatingOutperform$30.00 ➝ $25.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$15.00N/A
10/30/2017Jefferies Financial GroupSet Price TargetBuy$24.00 ➝ $20.00N/A
10/15/2017SunTrust BanksSet Price TargetHold$15.00N/A
9/28/2017Robert W. BairdReiterated RatingBuy$23.00High
9/25/2017Royal Bank of CanadaReiterated RatingHold$19.00High
9/21/2017Jefferies Financial GroupReiterated RatingBuy$24.00Low
9/14/2017MizuhoReiterated RatingNeutral$14.00Medium
9/14/2017CitigroupReiterated RatingHold$16.00Medium
9/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$24.00Low
8/24/2017Robert W. BairdReiterated RatingBuy$23.00Low
8/24/2017Royal Bank of CanadaReiterated RatingHold$25.00Low
8/20/2017MizuhoReiterated RatingNeutral$14.00High
8/20/2017SVB LeerinkReiterated RatingOutperform$23.00 ➝ $30.00High
8/10/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$28.00 ➝ $24.00Low
8/10/2017CitigroupReiterated RatingNeutral$20.00 ➝ $16.00Medium
8/10/2017Robert W. BairdReiterated RatingOutperform$23.00Medium
8/9/2017Credit Suisse GroupLower Price TargetNeutral$20.00 ➝ $17.00Low
8/8/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$26.00 ➝ $24.00High
7/18/2017Royal Bank of CanadaReiterated RatingHold$25.00Medium
6/6/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$27.00Medium
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$19.00High
6/6/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$22.00Low
5/15/2017Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $20.00Medium
5/5/2017Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $20.00Low
4/29/2017Jefferies Financial GroupReiterated RatingBuy$28.00 ➝ $26.00Low
4/23/2017MizuhoReiterated RatingNeutral$18.00Low
4/13/2017Jefferies Financial GroupReiterated RatingBuy$28.00Low
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$28.00High
3/27/2017MizuhoLower Price TargetNeutral$22.50 ➝ $18.00High
3/6/2017CitigroupLower Price TargetNeutral$22.00 ➝ $20.00N/A
3/3/2017Royal Bank of CanadaReiterated RatingHold$25.00N/A
2/24/2017MizuhoUpgradeUnderperform ➝ Neutral$13.00 ➝ $22.80N/A
2/6/2017Jefferies Financial GroupLower Price TargetBuy$36.00 ➝ $28.00N/A
1/24/2017SVB LeerinkReiterated RatingMarket Perform$22.00N/A
1/11/2017UBS GroupReiterated RatingBuy$26.00 ➝ $24.00N/A
1/3/2017Piper Jaffray CompaniesInitiated CoverageNeutral$16.00N/A
11/22/2016MizuhoDowngradeNeutral ➝ Underperform$13.00N/A
11/10/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
11/10/2016UBS GroupDowngradeOutperform ➝ Market PerformN/A
11/9/2016Bank of AmericaDowngradeBuy ➝ Neutral$32.00 ➝ $25.00N/A
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/A
(Data available from 10/19/2016 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 6 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
  • 7 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 7 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Tenet Healthcare logo
Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.
Read More

Today's Range

Now: $65.85
Low: $63.52
High: $66.60

50 Day Range

MA: $70.15
Low: $61.02
High: $75.98

52 Week Range

Now: $65.85
Low: $24.15
High: $76.15


34,252 shs

Average Volume

943,016 shs

Market Capitalization

$7.05 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Mizuho, Piper Sandler, Raymond James, Royal Bank of Canada, Seaport Global Securities, Seaport Res Ptn, Smith Barney Citigroup, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Securities, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for THC.

What is the current price target for Tenet Healthcare?

16 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $69.93, suggesting a possible upside of 9.9%. Credit Suisse Group AG has the highest price target set, predicting THC will reach $88.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $36.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 5 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected] The official website for Tenet Healthcare is www.tenethealth.com.